Jci_page_head_homepage_01 Jci_page_head_homepage_02
Chrystal M. Paulos, Claudia Wrzesinski, Andrew Kaiser,, Christian S. Hinrichs, Marcello Chieppa, Lydie Cassard, Douglas C. Palmer, Andrea Boni, Pawel Muranski, Zhiya Yu, Luca Gattinoni, Paul A. Antony, Steven A. Rosenberg, Nicholas P. Restifo
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2197–2204 doi:10.1172/JCI32205
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5
Depletion of cytokine sinks, removal of Tregs, and activation of the innate immune system recapitulate the effectiveness of TBI.

(A) Activation of the innate immune system with serum LPS, depletion of Tregs with anti-CD4 antibody, and removal of cytokine sinks with anti-NK antibody are required to improve the efficacy of adoptively transferred in nonirradiated mice. Tumor-bearing C57BL/6 mice received 5 Gy TBI or were left nonirradiated. Alternatively, mice were depleted of lymphocytes with CD4 and NK antibodies; 1 day later mice received 5 × 105 cultured pmel-1 T cells, rFPhgp100 vaccination, and IL-2. Serum for irradiated mice containing LPS was harvested and transferred into nonirradiated recipients. (B) Ultrapure LPS enhanced treatment in lymphodepleted nonirradiated mice. C57BL/6 mice were irradiated as a control. Mice received serum with translocated LPS or ultrapure LPS alone, CD4 alone, or NK-depleting antibody alone 1 day after ACT. Data (mean ± SEM; n = 4–5 per group) are representative of 2 independent experiments. (C) Ultrapure LPS recapitulated the effectiveness of TBI in Rag2–/–γc–/– mice genetically deficient in all lymphocytes. Data (mean ± SEM; n = 5 per group) are representative of 2 independent experiments. P = 0.05 versus irradiated treated mice. The difference between the nonirradiated, treated, LPS-administered group and the irradiated treated group was not significant (P < 0.2).